Search

Your search keyword '"Lowe, V."' showing total 637 results

Search Constraints

Start Over You searched for: Author "Lowe, V." Remove constraint Author: "Lowe, V."
637 results on '"Lowe, V."'

Search Results

251. Applicable law in investor-state arbitration: the interplay between national and international law

252. EO5 - 11C-choline PET-guided salvage intensity modulated radiotherapy with simultaneous integrated boost for isolated pelvic and para-aortic prostate cancer nodal recurrences: Minimal adverse effects.

253. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

255. MOPRA CO OBSERVATIONS OF THE BUBBLE H II REGION RCW 120.

258. Integration of Hydrogen-Deuterium Exchange Mass Spectrometry with Molecular Dynamics Simulations and Ensemble Reweighting Enables High Resolution Protein-Ligand Modeling.

261. Risky Business. Interventions to Prevent Aggression Against Health Workers From Patients at Risk: An Integrative Review.

263. Zeroing in on Xylazine.

264. The yes-no reversal phenomenon in patients with primary progressive apraxia of speech.

267. Reducing the risks when using benzodiazepines to treat insomnia: A public health approach.

268. Preliminary study on the dynamic positron emission tomography imaging with 11 C-ER176 to delineate macrophage activation in diabetic gastroparesis.

269. Do Not Overlook Bupropion Misuse.

270. The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features.

271. Marked Decreased Tracer Binding in 123 I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report.

274. A practical guide for buprenorphine initiation in the primary care setting.

276. TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease.

278. Management of blood pressure in pregnancy: new perspectives from the CHAP trial.

283. Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder.

284. Treating ADHD and Comorbid Anxiety in Children: A Guide for Clinical Practice.

287. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.

289. A computational model of neurodegeneration in Alzheimer's disease.

291. Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration.

292. Cerebrospinal fluid dynamics and discordant amyloid biomarkers.

293. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes.

295. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal.

296. Effective Partnership Care Models with Advanced Practice Psychiatric Nurses.

297. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.

298. Initial Results of a Phase 2 Trial of 18 F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma.

299. Can You Teach Resilience?

300. Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OS.

Catalog

Books, media, physical & digital resources